This quarterly earnings call will be available via phone and webcast.
WALTHAM, Mass., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Tesaro (NASDAQ:TSRO) will announce its third-quarter 2017 financial results on Tuesday, November 7, 2017, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 7, 2017 to discuss the Company’s operating results in greater detail, as well as the status of its development programs and the VARUBI/Y® and ZEJULA® launches.
This quarterly earnings call will be available via phone and webcast. The conference call dial-in information is listed below. To access the webcast, please log on to the TESARO website at www.tesarobio.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.
CONFERENCE CALL & WEBCAST INFORMATION
TESARO will host a conference call and live audio webcast to discuss its third-quarter financial results.
WHEN: Tuesday, November 7, 2017 at 4:15 p.m. ET
LIVE DOMESTIC & CANADA CALL-IN: (877) 853-5334
LIVE INTERNATIONAL CALL-IN: (970) 315-0307
THIS CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY, VIA THE WEB AT: www.tesarobio.com
A replay will be available for 30 days at www.tesarobio.com.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
Investor/Media Contact:
Jennifer Davis
Vice President, Corporate Communications and Investor Relations
+1.781.325.1116 or jdavis@tesarobio.com
